8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer

NCT01935492 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

420

Enrollment

NETWORK

Sponsor class

Conditions

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Metastatic Breast Cancer

Interventions

DRUG: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine
DRUG: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine

Sponsor

Borstkanker Onderzoek Groep

Collaborators

[object Object]
[object Object]